M. Segarra-Mondejar, S. Casellas-Díaz, M. Ramiro-Pareta, C. Müller-Sánchez, A. Martorell-Riera, I. Hermelo, M. Reina, J. Aragonés, O. M. Martínez-Estrada, and F. X. Soriano, “Synaptic activity-induced glycolysis facilitates membrane lipid provision and neurite outgrowth.,” EMBO J., p. e97368, Apr. 2018. EMBJOJ cover April 2018


Marc Segarra-Mondejar , Sergi Casellas-Díaz, Marina Ramiro-Pareta, Alejandro Martorell-Riera , Ismaïl Hermelo-Akhtar, Manuel Reina, Julián Aragonés, Ofelia M. Martínez-Estrada, Francesc X. Soriano

[resumenThe formation of neurites is an important process affecting the cognitive abilities of an organism. Neurite growth requires the addition of new membranes, but the metabolic remodeling necessary to supply lipids for membrane expansion is poorly understood. Here, we show that synaptic activity, one of the most important inducers of neurite growth, transcriptionally regulates the expression of neuronal glucose transporter Glut3 and rate‐limiting enzymes of glycolysis, resulting in enhanced glucose uptake and metabolism that is partly used for lipid synthesis. Mechanistically, CREB regulates the expression of Glut3 and Siah2, the latter and LDH activity promoting the normoxic stabilization of HIF‐1α that regulates the expression of rate‐limiting genes of glycolysis. The expression of dominant‐negative HIF‐1α or Glut3 knockdown blocks activity‐dependent neurite growth in vitro while pharmacological inhibition of the glycolysis and specific ablation of HIF‐1α in early postnatal mice impairs the neurite architecture. These results suggest that the manipulation of neuronal glucose metabolism could be used to treat some brain developmental disorders.




La formación de nuevas neuritas es un proceso clave para el correcto desarrollo del sistema nervioso. El crecimiento neurítico requiere la generación de nuevas membranas. No obstante, los cambios metabólicos que hacen posible la síntesis de estas han sido poco estudiados. En este artículo, mostramos que la actividad sináptica, uno de los principales inductores del crecimiento neuronal, incrementa el transporte de glucosa y su metabolismo con el objetivo de promover la síntesis de lípidos destinados al crecimiento neurítico. La inducción de ambos procesos se da a nivel transcripcional. La activación del factor de transcripción CREB activa la expresión de Glut 3, el principal transportador de glucosa en neuronas, y de Siah2, implicado en la estabilización de HIF-1a. HIF-1a, por último, es el encargado de inducir la transcripción de los genes limitantes del metabolismo de la glucosa. Estos resultados abren una nueva vía en el tratamiento de enfermedades que afectan al desarrollo del sistema nervioso central.



Foto grupomayo2018



El grupo dirigido por el Dr. Francesc X. Soriano se centra en el estudio de los mecanismos moleculares que determinan la muerte o la supervivencia neuronal. A pesar de la gran variedad de enfermedades neurodegenerativas la mayoría de ellas presentan problemas en la función mitocondrial. En nuestro grupo estudiamos cómo la viabilidad neuronal se ve afectado por cambios en la dinámica mitocondrial. Por otro lado, es bien sabido que la actividad sináptica juega un papel clave en neuroprotección. Por lo tanto tratamos de determinar qué vías pro-supervivencia son reguladas por la actividad sináptica y como podemos inducirlas para tratar enfermedades neurodegenerativas.

 Descargar el artículo 

Did you publish an interesting article recently?

Send it through our application form and we will contact you. Age limit: 32.

The selected articles will participate at the Award to the best article of young people of the SEBBM which will be given during SEBBM conference, that will take place at Spain (free registration, travel and accommodation).

More articles of the month

Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a Tripartite Interaction


Actinoporins are a group of soluble toxic proteins that bind to membranes containing sphingomyelin (SM) and oli- gomerize to form pores. Sticholysin II (StnII) is a member of the actinoporin...

Read more

Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour


To satisfy its high energetic demand, the brain depends on the metabolic cooperation of various cell types. For example, astrocytic-derived lactate sustains memory consolidation by serving both as an oxidizable...

Read more

Glucose restriction promotes osteocyte specification by activating a PGC-1α-dependent transcriptional program


Osteocytes, the most abundant of bone cells, differentiate while they remain buried within the bone matrix. This encasement limits their access to nutrients and likely affects their differentiation, a process...

Read more

ParB dynamics and the critical role of the CTD in DNA condensation unveiled by combined force-fluorescence measurements


/Bacillus subtilis/ ParB forms multimeric networks involving non-specific DNA binding leading to DNA condensation. Previously, we found that an excess of the free C-terminal domain (CTD) of ParB impeded DNA...

Read more

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer


Although human epidermal growth factor receptor 2 (HER2)-targeted therapies have dramatically improved the clinical outcome of HER2-positive breast cancer patients, innate and acquired resistance remains an important clinical challenge. New...

Read more

p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton


Planar cell polarity (PCP) and intercellular junctional complexes establish tissue structure and coordinated behaviors across epithelial sheets. In multiciliated ependymal cells, rotational and translational PCP coordinate cilia beating and direct...

Read more

β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9R239X mice


Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In...

Read more

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons


Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons, a process that current therapeutic approaches cannot prevent. In PD, the typical pathological hallmark is the accumulation of...

Read more

Dynamic acetylation of cytosolic phosphoenolpyruvate carboxykinase toggles enzyme activity between gluconeogenic and anaplerotic reactions


Cytosolic phosphoenolpyruvate carboxykinase (PCK1) is considered a gluconeogenic enzyme; however, its metabolic functions and regulatory mechanisms beyond gluconeogenesis are poorly understood. Here, we describe that dynamic acetylation of PCK1 interconverts...

Read more

The Helicase PIF1 Facilitates Resection overSequences Prone to Forming G4 Structures


DNA breaks are complex lesions that can be repaired either by non-homologous end joining (NHEJ) or by homologous recombination (HR). The decision between these two routes of DNA repair is...

Read more

Protector Members